Inspire medical systems, inc. (INSP)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Operating activities
Net loss

-16,245

-9,080

-8,247

-7,650

-8,266

-4,778

-4,693

-5,856

-6,501

-4,251

-4,023

-4,756

-4,481

Adjustments to reconcile net loss:
Depreciation and amortization

187

153

133

106

103

105

100

98

90

111

75

56

43

Accretion of investment discount

80

137

237

300

309

648

0

0

0

-

-

-

-

Accretion of debt discount

54

54

53

51

110

112

117

126

213

84

85

85

61

Non-cash lease expense

243

-

-

-

204

-

-

-

-

-

-

-

-

Stock-based compensation expense

2,749

1,893

1,524

1,389

1,391

523

372

269

55

54

81

54

54

Non-cash stock issuance for services rendered

72

59

58

58

58

58

37

0

0

-

-

-

-

Change in the fair value of preferred stock warrants

-

-

-

-

-

0

0

123

-718

-

-

-

-

Other, net

89

0

2

0

141

-51

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-2,092

2,102

1,577

2,416

385

1,284

922

1,029

-399

662

681

236

188

Inventories

1,411

1,159

1,114

455

439

-408

-473

154

-276

627

33

-183

-162

Prepaid expenses and other current assets

-775

-961

-2,375

4,453

-212

708

11

-1,154

1,761

215

24

22

47

Accounts payable

1,372

-410

2,189

-523

-222

988

204

-1,671

918

1,380

268

50

127

Accrued expenses and other liabilities

-4,494

2,788

1,901

1,513

-3,258

2,584

770

1,052

-825

749

1,125

559

-1,091

Net cash used in operating activities

-14,775

-6,076

-2,944

-12,884

-10,942

-2,589

-3,553

-6,134

-6,418

-3,277

-3,127

-4,027

-5,360

Investing activities
Purchases of property and equipment

255

442

1,064

958

275

191

0

52

7

62

124

20

206

Purchases of investments

14,907

34,550

42,487

60,464

40,573

16,545

93,798

496

4,642

-

-

-

-

Proceeds from sales or maturities of investments

82,403

15,000

43,050

22,400

56,804

20,358

1,764

5,146

5,074

-

-

-

-

Net cash provided by investing activities

67,241

-19,992

-501

-39,022

15,956

3,622

-92,034

4,598

425

-2,448

-4,926

-20

-206

Financing activities
Proceeds from issuance of notes payable

-

-

-

-

-

0

0

0

8,000

0

0

0

458

Payment of debt fees

0

0

0

0

531

0

0

0

0

-

-

-

-

Proceeds from the exercise of stock options and warrants

787

179

192

604

165

127

45

201

185

140

86

3

6

Proceeds from sale of preferred stock

-

-

-

-

-

-

-

-

-

0

0

0

24,968

Net cash provided by (used in) financing activities

787

897

192

1,241

-366

69,910

46

112,242

8,185

140

86

3

25,432

Effect of exchange rate on cash

4

-13

29

-12

9

33

0

0

0

-

-

-

-

Increase in cash and cash equivalents

53,257

-25,184

-3,224

-50,677

4,657

70,976

-95,541

110,706

2,192

-5,585

-7,967

-4,044

19,866

Supplemental cash flow information
Cash paid for interest

471

471

475

316

771

566

560

546

347

339

341

335

308

Issuance of preferred stock warrants

-

-

-

-

-

0

0

0

103

0

0

0

4